HOME >> BIOLOGY >> NEWS
Preeclampsia in pregnancy increases risk of future cardiovascular disease and death

In a study of mothers with a history of preeclampsia, a hypertension complication in pregnancy affecting five percent of all women, researchers at Yale have found that these women have an increased lifetime risk for cardiovascular illness and death.

"Even when a mother's blood pressure returns to normal after delivery, preeclampsia might increase her risk of lifethreatening cardiovascular disease," said lead author Edmund F. Funai, M.D., associate professor and cochief, Division of MaternalFetal Medicine in the Department of Obstetrics, Gynecology & Reproductive Sciences.

Funai and his team published their findings in the March issue of Epidemiology. They studied deaths among 37,061 women who had given birth in Jerusalem between 1964 and 1976, including 1,070 women with preeclampsia. They used a method called Cox proportional hazard models to investigate the longterm risk of mortality in women with preeclampsia. They controlled for a woman's age and education, history of diabetes, heart disease and low birth weight, the husband's social class, and the calendar year at the start of followup.

"Women with a history of preeclampsia had a twofold risk of death compared with women without any history of the disorder," said Funai. "We also found that women diagnosed with preeclampsia who had a subsequent normal birth were still 2.6 times as likely to die after 20 years of followup than women with no history." Currently, the only cure for preeclampsia is delivery. Funai said that a normal blood pressure after preeclampsia should not discourage the search for other cardiovascular risk factors or overshadow the need for other preventive measures.

Other authors on the study included Yechiel Friedlander, Ora Paltiel, Efrat Tiram, Xiaonan Xue, Lisa Deutsch and Susan Harlap.


'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
12-Apr-2005


Page: 1

Related biology news :

1. Preeclampsia, fetal development problems may be linked to low levels of hormone
2. Losing weight after pregnancy -- diet and exercise better than diet alone
3. Complementary therapy for infertile women may reduce chances of pregnancy
4. Pre-implantation genetic screening reduces both ongoing pregnancy and live birth rates in over 35s
5. Personalized approach to ovarian stimulation achieves high ART pregnancy rates
6. Noninvasive screening in early pregnancy reduces Downs births by 50 percent
7. Its safe for obese moms-to-be to lose weight during pregnancy, new SLU research finds
8. Alcohol use during pregnancy leads to greater risk of extreme preterm delivery
9. Migraines during pregnancy linked to stroke and other vascular diseases
10. Malaria in pregnancy: What can the social sciences contribute?
11. Apple consumption during pregnancy reduces risk for childhood wheezing and asthma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... , ... February 06, 2020 ... ... research organization (CRO) specializing in complex interventional medical device and pharmaceutical trials, ... Regulatory Strategy. In this newly established role, Dorothy oversees the development and ...
(Date:2/1/2020)... ... , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each year in more ... is the 5th most common cancer and the 2nd leading cause of cancer deaths. ... of HCC, while China has half of all patients suffering from liver cancer. The ...
(Date:1/29/2020)... Texas (PRWEB) , ... January 29, 2020 , ... ... DNA plasmid, announced it will start production of a DNA vaccine against the ... executed with Inovio Pharmaceuticals. A grant of up to $9 million from the ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... Conn. (PRWEB) , ... February 04, 2020 , ... ... develops tools for characterizing microbiome populations down to the strain level, has announced ... will sell Shoreline Biome’s microbiome kits and other products to companies and research ...
(Date:2/3/2020)... BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) , ... ... ... headquartered in Budapest with US offices in Cambridge, MA, announce that OmniType, the ... Access Program (EAP) from today. OmniType is a best-in-class product featuring locus-multiplexing and ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive ... Center in New Jersey epitomize the notion that plastic surgery is much more than ... in popular media. , Over the last 20 years NJ Top Docs, Dr. Andrew ...
Breaking Biology Technology:
Cached News: